Novo Holdings A/S - Feb 7, 2025 Form SCHEDULE 13G Schedule Report for ArriVent BioPharma, Inc.

Filing Manager: Novo Holdings A/S
Reporting Manager: Novo Holdings A/S
Security: ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share
Shares outstanding: 33.7M shares
Disclosed Ownership: 1.75M shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 09:00 PM
Date of event: Feb 7, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Novo Holdings A/S	5.2%	1.75M	1.75M	0	Barbara Fiorini	Barbara Fiorini, General Counsel, Finance & Operations